Two Sigma Investments, LP Nuvectis Pharma, Inc. Transaction History
Two Sigma Investments, LP
- $50.6 Billion
- Q2 2025
A detailed history of Two Sigma Investments, LP transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 18,135 shares of NVCT stock, worth $123,862. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,135
Previous 20,093
9.74%
Holding current value
$123,862
Previous $196,000
31.12%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NVCT
# of Institutions
48Shares Held
3.2MCall Options Held
44.5KPut Options Held
50.1K-
Vanguard Group Inc Valley Forge, PA667KShares$4.55 Million0.0% of portfolio
-
Ronit Capital LLP563KShares$3.84 Million5.37% of portfolio
-
Iridian Asset Management LLC373KShares$2.55 Million1.01% of portfolio
-
Baldwin Brothers LLC350KShares$2.39 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA285KShares$1.95 Million0.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $100M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...